4Langer K, Coester C, Weber C, et al. Preparation of avidin- labeled protein nanoparticles as carriers for biotiny -lated peptide nucleic acid. Eur J Pharm Biopharm, 2000, 49 (3): 303-307. 被引量：1
5Chen CO, Lin W, Coombes AG, et al. Preparation of human serum albumin microspheres by a novel acetone- heat denaturation method. J Microencapsul, 1994, 11 (4): 395 - 407. 被引量：1
6Weber C, Coester C, Kreuter J, et al. Desolvation process and surface characterisation of protein nanoparticles. Int JPharm, 2000, 194 (1) : 91 - 102. 被引量：1
7Longo WE, Iwata H, LindheimerTA, et al. Preparation of hydrophilic albumin microspheres using polymeric dispersing agents. JPharmSci, 1982, 71 (12): 1323-1328. 被引量：1
8Latha MS, Jayakrishnan A. A new method for the synthesis of smooth, round, hydrophilic protein microspheres using low concentrations of polymeric dispersing agents. J Microeneapsul, 1995, 12 (1): 7-12. 被引量：1
9Meziani MJ, Sun YP. Prntein-conjugated nanourtieles from rapid expansion of supereritieal fluid lution into aqueous, solution J J. J Am Chem Soc. 2003, 125 (26) : 8015 -8018. 被引量：1
8Santhi K, Dhanaraj SA, Joseph V, et al. A study on the preparation and anti-tumor efficacy of bovine serum albumin nanospheres containing 5-fluorouracil [J]. Drug Dev Ind Pharm, 2002,28(9): 1171. 被引量：1
9Moghimi SM, Hunter AC, Murray JC. Long-circulating and targetspecific nanoparticles: theory to practice [J]. Pharmacol Rev,2001, 53(2): 283. 被引量：1
10Langer K, Coester C, von Briesen H, etal. Preparation of avidin-labeled protein nanoparticles as carriers for biotinylated peptide nucleic acid (PNA) [J]. Eur J Pharm Biopharm,2000,49(3): 303. 被引量：1
6Maheshwari R K, Singh A K, Gaddipati J, et al. Multiple biological activities of curcumin:A sbort review [J]. Life Sci, 2006, 78 (18) :2081. 被引量：1
7Sharma R, GescherA J, McLelland H R, et al. Pharmacoldynamic and pharmacokinetic study of oral curcuma extract in patients with colorectal cancer[ J]. Clin Cancer Res, 2001, 7 (7) : 1894. 被引量：1
8Qiang Fu, Jin Sun, Wenping Zhang, et al. Nanoparticle albuminbound ( NAB ) technology is a promising method for anti-cancer drug dehvery[ J]. Recent Patents on Anti-Cancer Drug Discovery, 2009, 4: 262. 被引量：1
10Arnedo A, Espuelas S, Irache MJ. Albumin nanoparticles as carriers for a phosphodiester oligonucleotide EJ]. lnt J Pharm, 2002, 244 (1-2) : 59-72. 被引量：1
